4//SEC Filing
Gagnon Robert E. 4
Accession 0000905148-25-003320
CIK 0001228627other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 6:03 PM ET
Size
7.3 KB
Accession
0000905148-25-003320
Insider Transaction Report
Form 4
Gagnon Robert E.
Chief Financial Officer
Transactions
- Award
Common Stock
2025-09-10+200,000→ 200,000 total - Award
Employee Stock Option (right to buy)
2025-09-02+250,000→ 250,000 totalExercise: $1.23Exp: 2035-09-01→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.
Documents
Issuer
Opus Genetics, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001504983
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 6:03 PM ET
- Size
- 7.3 KB